Novartis has allied with Microsoft to leverage the latter’s artificial intelligence (AI) technology for the discovery, development and commercialisation of medicines. Under the multi-year collaboration, Novartis established an AI innovation lab, where the pharmaceutical company’s […]
Pfizer has expanded its collaboration with oncology software provider Flatiron Health to integrate and increase the application of real-world data further in its development of targeted cancer drugs. As per the agreement terms, Pfizer will […]
Hansoh Pharmaceutical Group Company, a leading biopharmaceutical company in China, and Atomwise, the leader in artificial intelligence (AI) for drug discovery, have announced a collaboration to design and discover potential drug candidates for up to […]
US biotech company Insilico Medicine has developed a new artificial intelligence (AI) system for drug discovery, known as GENTRL. The Maryland-based Insilico Medicine claimed that GENTRL can fast track the drug discovery process from years […]
Immuno-oncology company Mateon Therapeutics has signed a definitive agreement to merge with PointR Data, a computer and artificial intelligence (AI) company, to form an AI-driven firm focused on cancer treatment. The new firm will feature […]